Q32 Bio Inc.: Clear Street initiates coverage with buy rating; price target $38
QTTB•Clear Street initiated coverage of Q32 Bio with a buy rating and a $38 price target.
Related News
Valvoline increases share repurchase authorization
VVV•
Canada press digest - September 29
BRX•
Scholastic to acquire Cottage Door Press for about $71 million
SCHL•
Sherwin-Williams enters new 364-day senior unsecured term loan agreement on Sept. 24, 2026
SHW•
Metalpha raises 2024 share incentive plan limit to 5,000,000 shares from 2,000,000
MATH•